DK0874640T3 - Cyclosporinformulering - Google Patents

Cyclosporinformulering

Info

Publication number
DK0874640T3
DK0874640T3 DK97901147T DK97901147T DK0874640T3 DK 0874640 T3 DK0874640 T3 DK 0874640T3 DK 97901147 T DK97901147 T DK 97901147T DK 97901147 T DK97901147 T DK 97901147T DK 0874640 T3 DK0874640 T3 DK 0874640T3
Authority
DK
Denmark
Prior art keywords
pct
weight
compositions
dimethyl
sec
Prior art date
Application number
DK97901147T
Other languages
Danish (da)
English (en)
Inventor
Milan Stuchlik
Tomas Andrysek
Alexander Jegorov
Ales Husek
Vladimir Matha
Josef Stuchlik
Original Assignee
Ivax Pharmaceuticals Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Pharmaceuticals Sro filed Critical Ivax Pharmaceuticals Sro
Application granted granted Critical
Publication of DK0874640T3 publication Critical patent/DK0874640T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97901147T 1996-01-18 1997-01-17 Cyclosporinformulering DK0874640T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ1996169A CZ288631B6 (cs) 1996-01-18 1996-01-18 Léčivé přípravky s obsahem cyklosporinu
PCT/GB1997/000131 WO1997026003A1 (en) 1996-01-18 1997-01-17 Cyclosporin formulation

Publications (1)

Publication Number Publication Date
DK0874640T3 true DK0874640T3 (da) 2003-11-17

Family

ID=5461334

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97901147T DK0874640T3 (da) 1996-01-18 1997-01-17 Cyclosporinformulering

Country Status (12)

Country Link
US (1) US6046163A (cs)
EP (1) EP0874640B1 (cs)
JP (1) JP4005134B2 (cs)
KR (1) KR100471680B1 (cs)
AT (1) ATE245436T1 (cs)
AU (1) AU1449497A (cs)
CZ (1) CZ288631B6 (cs)
DE (1) DE69723671T2 (cs)
DK (1) DK0874640T3 (cs)
ES (1) ES2207714T3 (cs)
PT (1) PT874640E (cs)
WO (1) WO1997026003A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CZ283516B6 (cs) 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
CA2313024C (en) 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil
WO1999032105A1 (en) * 1997-12-23 1999-07-01 Dcv, Inc. Doing Business As Bio-Technical Resources Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
AU751753B2 (en) * 1998-03-04 2002-08-29 Ato B.V. Bicyclooctane derivatives as plasticisers
CN1245955C (zh) 1998-05-29 2006-03-22 斯凯伊药品加拿大公司 热保护微粒组合物及其最终蒸汽灭菌的方法
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
JP4809533B2 (ja) 1998-11-20 2011-11-09 オバン・エナジー・リミテッド 分散し得るリン脂質で安定化されたミクロ粒子
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
KR100801588B1 (ko) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 생물학적 유효 물질의 표면 변형된 미립자 조성물
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AUPQ877300A0 (en) * 2000-07-13 2000-08-03 Johnson & Johnson Pacific Pty Limited Topical treatment of skin
WO2003032949A1 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
AU2003240536B2 (en) * 2002-06-05 2007-11-15 Ivax Pharmaceuticals, S.R.O. Reduction of gelatin cross-linking
DE50308456D1 (de) * 2003-01-08 2007-12-06 Swiss Caps Rechte & Lizenzen Formkörper bestehend aus gelatinfreiem Material und gefüllt mit einer flüssigen Füllmasse
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
FR2971941B1 (fr) * 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
CA1326995C (en) * 1988-01-29 1994-02-15 Kozo Kurihara Cyclosporin compositions
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
EP0451461B1 (de) * 1990-02-23 1994-04-27 BASF Aktiengesellschaft Verwendung von Mischungen aus Polyglycerinfettsäureestern als Emulgatoren in kosmetischen und pharmazeutischen Zubereitungen
CZ278863B6 (en) * 1992-09-07 1994-07-13 Galena Medicinal preparations with n-methylated cyclic undecapeptides
CN1077800C (zh) * 1993-07-01 2002-01-16 韩美药品工业株式会社 环孢菌素软胶囊组合物
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
JPH08507247A (ja) * 1993-12-24 1996-08-06 フィリップス エレクトロニクス ネムローゼ フェンノートシャップ 読み取り傾斜極性補正及びｔ▲下２▼測定をもつｇｒａｓｅ型ｍｒｉ
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물

Also Published As

Publication number Publication date
JP2000503314A (ja) 2000-03-21
CZ16996A3 (en) 1997-08-13
WO1997026003A1 (en) 1997-07-24
US6046163A (en) 2000-04-04
CZ288631B6 (cs) 2001-08-15
PT874640E (pt) 2003-12-31
KR100471680B1 (ko) 2007-04-25
EP0874640A1 (en) 1998-11-04
ES2207714T3 (es) 2004-06-01
JP4005134B2 (ja) 2007-11-07
DE69723671T2 (de) 2004-04-22
DE69723671D1 (de) 2003-08-28
ATE245436T1 (de) 2003-08-15
EP0874640B1 (en) 2003-07-23
KR19990077360A (ko) 1999-10-25
AU1449497A (en) 1997-08-11

Similar Documents

Publication Publication Date Title
DE69723671D1 (de) Cyclosüporin formulierung
ES2183865T3 (es) Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol.
CY2233B1 (en) Compositions to treat onychomycoses
PT786986E (pt) Formulacoes farmaceuticas
AR030933A1 (es) Derivados del triazol y composiciones farmaceuticas que los contienen
HUP0002806A2 (hu) Funkcionális hatóanyagokat tartalmazó, módosított ízű kemény édesárukészítmények
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
GB0031312D0 (en) Macrolides
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
FI955403A (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
DK0535734T3 (da) Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
BG106155A (en) Novel derivatives and analogues of galanthamin
ES2012674A6 (es) Composicion artropodicida sinergica.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
HUP0001137A2 (hu) Bőrápoló szer
ATE308969T1 (de) Kosmetische formulierung enthaltend dihydroxyaceton
MXPA03000606A (es) Derivados de benzofurano y su uso como agentes antibacterianos.
ES2078378T3 (es) Composiciones que tienen actividad herbicida conteniendo n-alquil-amidas como ingrediente activo.
DE69207777D1 (de) Körperpflegemittel
IL77151A0 (en) Triazole derivatives,their use as fungicides and pharmaceutical compositions containing them
DE69501183T2 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
WO2000044334A3 (en) Novel injectable muscle relaxant formulations
ES2074985T3 (es) Derivados de benzopiran (4,3-d)-tiazol con actividad anti-alergica, anti-anafilactica y anti-artritica y composiciones que lo contienen.